Latest News

  • Liquid Biopsy Test Covers Landscape Of DNA-Based Microbial Pathogens

    Diagnostics World News | Merging biotech and infotech, life science company Karius has laid the groundwork for dramatically advancing molecular diagnostics for infectious diseases on a global scale, according to Chief Medical Officer (CMO) Brad Perkins, M.D. Using technology similar to what’s being used for detecting circulating tumor DNA, the Karius “liquid biopsy” test looks for microbial cell-free DNA (cfDNA) to accurately identify more than 1,000 pathogens from a single blood draw.

    Mar 18, 2022

  • Super Early Detection: Pan-Cancer Tests Aim to Catch Cancer Earlier than Ever

    Diagnostics World | In recent years, the race to develop a single test that can simultaneously screen for many cancers has heated up. Dozens of companies have thrown their hats in the ring, pursuing differing approaches to search for the very earliest signs of cancer. So where does this field currently stand? Where is it headed? And is extremely early cancer detection really possible?

    Mar 16, 2022